CUB cmp 166.50, heading higher to target 200 in one monthTechnically, CUB is heading higher with higher highs and higher lows, price above all short-term averages and averages heading higher forming a U-shaped pattern on a daily time so we strong expect a target of 200 in a month time frame. Aggressively bought for trading and investment purpose.
Ushape
Crude Oil BullishCrude breaking daily chart trendline and showing a U shape breakout. Everything Points to testing previous highs and price continues to make higher highs and higher lows. Not sure what could be the catalyst but there is the beginning of a repeating pattern from last June. Key resistance is at 85-87 and if price can push past this level its likely that a retest of support levels of 84 before a continuation higher. The next magnetic level after 85 is at the bearish order block level at 94.5.
Strong Buy Aartiinds cmp 645, target 740-745 in 10-15 sessionsAarti Industries Ltd manufactures and deals in Speciality Chemicals and Pharmaceuticals. Company has 21+ manufacturing units, 100+ products, 700+ domestic customers, 400+ export customers in 60+ countries with major presence in the USA, Europe, Japan, etc.
Product Profile:
a) Special Chemicals: Benzene, toluene, nitric acid, chlorine, methanol, aniline, sulphur, etc.
b) Pharmaceuticals: API, Intermediates, Xanthine Derivatives, CDMO
User Industries:
Polymer and additives, agrochemicals and intermediates, dyes, pigments, paints, and printing inks, pharma intermediates, fuel additives, rubber chemicals, resins, etc.
Clientele:
a) Polymers and Additives: BASF, Sojitz, Solvay, Teijin, Toray, Dupont, Sabia, Dic
b) Pigments, Paints, Printing Inks and Dyes: Huntsman, Clariant, Atul, Archroma, Sun Chemical, Sudarshan
c) Agro Intermediates & Fertilizers: Bayer, Sygenta, UPL, Gharda Chemicals, FMC, Makhteshim, Coromandel
Segmental Revenue:
In FY22, company generated revenue from Speciality Chemicals 84% and Pharmaceuticals 16%
Geographical Revenue Split:
In FY22, company generated revenue from Exports 44% which consisted of revenues from North America 11%, Europe 11%, China 5%, Japan 3% and rest of the world 11%
Demerger:
On 30th January 2023, company demerged its Pharma entity into a separate company viz. Aarti PharmLabs Limited after getting approval from NCLT Ahmedabad. Shareholders of the demerged company received 1 equity share of Rs. 5/- of the
Resulting Company for every 4 equity shares of Rs. 5/- held in the Demerged Company
Future Projects:
Company is adding new chemistries and 40+ Value added products for Chemical by doing CAPEX of Rs. 2,500-3,000 crore, and also doing site development work on 100+ acre land at Jhagadia, which is expected to be completed by FY24. These include:
a) USFDA capacity expansion underway: API unit at Tarapur and intermediate unit at Vapi
b) Expansion cum asset upgradation for acid unit at Vapi
c) Expansion, asset restoration, sustainability initiatives, etc.
d) Unit at Jhagadia for 3rd long-term contract
e) NCB capacity expansion at Vapi
Partnership:
On November 19th 2022, company signed a binding term-sheet with Deepak Fertilizers (DFPCL), for Nitric Acid off take and supply arrangement valued over ~Rs. 8,000 crore for a 20-year period. DFPCL will supply Nitric Acid to the company, at formula driven international prices from 1st April 2023
18th January, 2024: Aarti Industries Limited (AIL) announces the signing of a long-term agreement with a multinational conglomerate for supply of a niche speciality chemical. The contract entails supply over a period of four years and is anticipated to generate revenue of over Rs. 6000 crores for the Company.
Financial Performance:
Aarti Industries exhibited strong resilience and delivered robust performance with a 16% increase in absolute EBITDA compared to the previous quarter. Revenues increased by 2% to Rs. 1,597 crore in Q2 FY24 compared to the previous quarter. EBITDA grew by 16% on a Q-o-Q basis to Rs. 233 crore in Q2 FY24. Profit after tax stood at Rs. 91 crore in Q2 FY24, higher by 30% over the previous quarter.
Aarti Industries maintains optimism about potential demand revival in end-use segments such as agrochemical, polymer additives, and other discretionary applications. The company expects better performance in H2 FY24 and foresees FY25 as a normalizing year considering the current pace of recovery. The export market is showing stronger momentum compared to the domestic market. The company expects to sustain and grow its market share in the export market.
The demand for octane boosters, a key product, is growing, and the company expects to sustain and grow this demand. The company anticipates a gradual recovery in global demand and a decrease in competitive intensity. The company is progressing well with various expansion projects and expects to commission them in a phased manner from next year. Aarti Industries is committed to deploying Rs. 2,500 to 3,000 crore for growth initiatives over a two-year period.
The company is targeting commissioning of the ethylation and nitrotoluene projects in Q1 FY25. Margins have improved due to a better product mix and the recovery in demand for certain products. The company expects the bottoming out of margins in the first quarter and a gradual improvement going forward. The company is focused on optimizing staff costs and other expenses.The company expects FY25 to see a progressive increase in volume and EBITDA, with a quarter-on-quarter improvement in performance. The company expects to see a gradual recovery in volumes and margins in the second half of FY24.The net debt is expected to peak at around Rs. 2,700-2,900 crore in FY24. The company expects to see a normalization of business in FY25 as the demand recovers and inventory correction is completed. The company expects volume growth across various product lines in FY25, leading to an improvement in performance. The company's exports are predominantly to regular markets, with non-regular markets accounting for around 10% of exports. Margins in non-regular markets are generally lower, but the company expects the benefit of regular markets to accrue in the future.
Conclusion:
The company has a strong potential to grow as it has already signed big revenue contracts for long term and looking at a growth prospects, the share price can easily reach 900 in matter of 2 months. However for a technical trade, we see a good upside momentum and strong buying pattern, completing a big U-shaped recovery and expecting a target of 740-745 in next 10-15 trading sessions max.
MRNA, U Shape recoveryNASDAQ:MRNA technically setup for U-shape recovery and it has some positive news related to variants of the coronavirus in laboratory tests. The first resistance could be 169.
Disclaimer: I"m NOT a financial advisor. All trades idea are shared for educational purposes only. All advice is based on technical and my own opinion.
PTON, Breakout Setup for PT 169Setup shows U shape recovery and stock trying to break out. A huge volume indicates the crowd is anticipating a breakout here. Then room to go around 169 as per measure move. Wait for breakout, retests and holds support to confirm. The only concern is on RSI is enter into the overbought area.
Buy Area: 139
PT: 169
SL: 129.37
Disclaimer: I"m NOT a financial advisor. All trades idea are shared for educational purposes only. All advice is based on technical and my own opinion.
S&P 500 U Shape Recovery 2020-2022The impossible "V-shaped"
The year 2020, a bad memory quickly forgotten? No, warn more and more economists, alarmed by the violence of the shock in the first half. They expect a slow recovery, provided that a second wave of the new coronavirus does not strike.
The IMF has also made it clear that, despite the expected rebound, world GDP in 2021 would come out cut by 6.5% compared to what was expected before the pandemic.
Some sectors are affected for a long time, especially in services. Perfect example: tourism and travel. No catching up possible for empty rooms, meals never served, planes nailed to the ground. Did IATA, the international air transport association, not warn that it did not expect to return to normal before ... 2023?
In industry, factories face many health restrictions. Farmers all over the world are struggling due to the lack of foreign workers.
Exit therefore, the "V" scenario that some people were still hoping for in February. Rather, it is a "U-shaped" scenario that emerges at best, with several months of recession before the economy recovers. See a "W" with alternating rebounds and relapses. Or, worse yet, an "L" with depressed activity for a very long time.
U turn up on BK trading details......!!!By looking at the chart, it looks more similar a upside down mountain sloppy hill.
Recognizing this kind of a change can allow traders to take profits and protect themselves from buying into an unfavorable market, or strategics to make money from falling prices by short-selling.
The big question is that what will be the next move?
So basically it has many answers:
1st it can break the support line with heavy volume and move towards down direction.
2nd it can take the support and move towards up-direction not braking the support line.
3rd by moving slowly zig-zag not breaking the line and creating a value area.
ICX testing the sentiment of an apparent bottom. Trades active!The Trade:
Wait for correction to around 1080 or below and buy in.
Stop loss around 1029 (think about buying back in if we hit this)
Target 1150.
Discussion:
Looking on the daily chart at mid range we can see that ICX is playing around with trying to define a bottom after a long period of losses.
We can see that there was an inital pump that attempted to bring about a reversal followed by a channeling upward over time.
Recent U shaped reversal pattern is taken as a sign that there is high potential that the upward trend will continue.
Looking at a smaller time frame we can see that the rallies that ICX experiences are generally steep with roughly 70 - 50% pullback while they channel upward. Secondly, we can see that we have experianced a recent "double" pump of sentiment over the last 20 or so candles, forming the U type chart pattern that can be indicative of continued motion within the larger yellow channel region. However, betting on the side of strong sentiment we consider potentials within the smaller yellow channel within.
Keep a strong attention towards the blue support line and the orange resistance line as potential bounce & targets. Clear out your position if we break the blue line downwards and await new signal of sentiment.
Possible U-shape breakout $ONCSLooks good for a u-shape breakout as indicators are pointing up. Nice rounded bottom looking to test the red line for resistance and possible selling point.
Stellar Lumen (XLM) - Last Wave almost 2000% in 2 months!Hi Guys!
Another Monday... well let's start with something interesting.
I am sure you encountered problem with sending money abroad. It takes time and a lot of money. Western Union takes 10% fee of the amount transferred. 10% seriously? This is like additional tax!
So guys from Stellar decided to do something about it. You can tranfer for example EURO to JPY within a seconds for less than a penny. Seriously.
As we tested is it works super fast and very very cheap. Seminglessly.
Stellar is aiming to be an open financial system that gives people of all income levels access to low-cost financial services.
This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.
Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.
The have a great team (Jed McCaleb as a co-founder) and amazing board member (Matt Mullenweg - founder of Wordpress, Naval Ravikant - Founder of AngelList, Sam Caltman - president of Y Combinator). www.stellar.org
They are ranked on coingecko on 10th place overall with 86% regarding developers.
They have market cap over 3.5 bln $ ranked again in top 10.
So this is very solid project, massively backed by the team. This business is also socialy engaged as they want bank the unbanked part of the people (2 bln in total) who are considered too poor for banks to offer them financial services.
This might be the killer within couple of weeks and months.
Technical Analysis details:
MACD postivie divergence - strong bull's singal
Fibonacci Levels:
Entry - 0.000002176 - 0.000002885
Target 1: 0.000003614
Target 2: 0.000004499
Target 3: 0.000005218
Target 4: 0.000005918
Target 5: 0.000006902
Target 6: 0.000008192
Stop-loss: 0.000002176
We may go much further than this but we prefer to stay observant.
Just to remember you - last wave 2000% in just 2 months.
Thanks once again for your likes, interest and comments. You are AWESOME.
HUGE GUGS!